- Home
- MUX vs XERS Comparison
MUX vs XERS Comparison
Compare MUX & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- XERS
- Stock Information
- Founded
- MUX 1979
- XERS 2005
- Country
- MUX Canada
- XERS United States
- Employees
- MUX N/A
- XERS N/A
- Industry
- MUX Precious Metals
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- XERS Health Care
- Exchange
- MUX Nasdaq
- XERS Nasdaq
- Market Cap
- MUX 501.8M
- XERS 444.0M
- IPO Year
- MUX N/A
- XERS 2018
- Fundamental
- Price
- MUX $8.78
- XERS $3.47
- Analyst Decision
- MUX Strong Buy
- XERS Strong Buy
- Analyst Count
- MUX 2
- XERS 3
- Target Price
- MUX $15.63
- XERS $4.67
- AVG Volume (30 Days)
- MUX 542.1K
- XERS 1.3M
- Earning Date
- MUX 11-05-2024
- XERS 11-08-2024
- Dividend Yield
- MUX N/A
- XERS N/A
- EPS Growth
- MUX N/A
- XERS N/A
- EPS
- MUX 2.07
- XERS N/A
- Revenue
- MUX $199,634,000.00
- XERS $181,413,000.00
- Revenue This Year
- MUX $28.57
- XERS $20.35
- Revenue Next Year
- MUX $11.77
- XERS $16.14
- P/E Ratio
- MUX $4.48
- XERS N/A
- Revenue Growth
- MUX 47.02
- XERS 35.31
- 52 Week Low
- MUX $5.92
- XERS $1.46
- 52 Week High
- MUX $12.50
- XERS $3.42
- Technical
- Relative Strength Index (RSI)
- MUX 38.57
- XERS 72.62
- Support Level
- MUX $8.46
- XERS $3.10
- Resistance Level
- MUX $9.70
- XERS $3.32
- Average True Range (ATR)
- MUX 0.44
- XERS 0.17
- MACD
- MUX -0.18
- XERS 0.01
- Stochastic Oscillator
- MUX 21.90
- XERS 75.73
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.